Cargando…

AI-based spectroscopic monitoring of real-time interactions between SARS-CoV-2 and human ACE2

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), invades a human cell via human angiotensin-converting enzyme 2 (hACE2) as the entry, causing the severe coronavirus disease (COVID-19). The interactions between hACE2 and the spike glycoprotein (S protein) of SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Sheng, Zhang, Guozhen, Jiang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Physical Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256048/ https://www.ncbi.nlm.nih.gov/pubmed/34185681 http://dx.doi.org/10.1073/pnas.2025879118

Ejemplares similares

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
por: Bauer, Magnus S., et al.
Publicado: (2022)

Cross-species recognition of SARS-CoV-2 to bat ACE2
por: Liu, Kefang, et al.
Publicado: (2021)

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)

The functional motif of SARS-CoV S protein involved in the interaction with ACE2
por: Zhang, Yi, et al.
Publicado: (2009)

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
por: Mehdipour, Ahmad Reza, et al.
Publicado: (2021)

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
por: Qiao, Yuanyuan, et al.
Publicado: (2021)

SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
por: Yu, Shi, et al.
Publicado: (2021)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
por: Anand, Sai Priya, et al.
Publicado: (2020)

SARS-CoV-2 Variants Monitoring Using Real-Time PCR
por: Esman, Anna, et al.
Publicado: (2022)

Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions
por: Christie, Shaun M., et al.
Publicado: (2022)

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Yang, Jinsung, et al.
Publicado: (2020)

Is there a role for the ACE2 receptor in SARS‐CoV‐2 interactions with platelets?
por: Campbell, Robert A., et al.
Publicado: (2021)

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
por: Brown, Emily E. F., et al.
Publicado: (2021)

Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction
por: Lan, Jun, et al.
Publicado: (2022)

Interaction of SARS-CoV-2 With RAS / ACE2 in the Female Reproductive System
por: Zafari Zangeneh, Farideh
Publicado: (2022)

Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates
por: Damas, Joana, et al.
Publicado: (2020)

Distinct Differences in the Interactions of Receptor Binding Domains of SARS-CoV-2 and SARS-CoV with Human ACE2
por: Acharya, Atanu, et al.
Publicado: (2021)

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2–ACE2 Receptor Interactions
por: Day, Christopher J., et al.
Publicado: (2021)

An inducible hACE2 transgenic mouse model recapitulates SARS-CoV-2 infection and pathogenesis in vivo
por: Liu, Kuo, et al.
Publicado: (2023)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2 Interactions
por: Forssén, Patrik, et al.
Publicado: (2020)

SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets
por: Raghuvamsi, Palur V, et al.
Publicado: (2021)

Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction
por: Ngo, Van A., et al.
Publicado: (2021)

SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism
por: Shen, Shu, et al.
Publicado: (2021)

A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions
por: Bauer, Magnus S., et al.
Publicado: (2022)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
por: Pei, Gaofeng, et al.
Publicado: (2022)

SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19
por: Nesci, Salvatore
Publicado: (2021)

ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion
por: Zhang, Qiangmin, et al.
Publicado: (2021)

Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction
por: Singh, Ruhar, et al.
Publicado: (2022)

An ace model for SARS-CoV-2 infection
por: Major, Jack, et al.
Publicado: (2020)

SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
por: Datta, Prasun K., et al.
Publicado: (2020)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction
por: Biagioli, Michele, et al.
Publicado: (2021)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

Protocol for infecting and monitoring susceptible k18-hACE2 mice with SARS-CoV-2
por: Couto, Joana, et al.
Publicado: (2023)

Thermodynamic analysis of the interactions between human ACE2 and spike RBD of Betacoronaviruses (SARS‐CoV‐1 and SARS‐CoV‐2)
por: Rombel‐Bryzek, Agnieszka, et al.
Publicado: (2022)

SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ql0rlbhtgsbsg25rds1a57nttn